The drugmaker said it is the only U.S. company with FDA-approved medications containing semaglutide, the active ingredient for Ozempic, Wegovy and Rybelsus, and unapproved compounded solutions with semaglutide jeopardize public health, according to court documents. Novo Nordisk also accused the compounding pharmacies of unfair competition and hurting the drug company’s reputation.
The three Florida pharmacies are Live Well Drugstore in Green Cove Springs, WellHealth in Jacksonville and Brooksville Pharmaceuticals in Brooksville. Novo Nordisk requests at least $75,000 from each location.
This is the second time Novo Nordisk has sued over Ozempic copycats. In June, it filed suit against six spas and clinics for similar allegations.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
